questionsmedicales.fr
Phénomènes génétiques
Variation génétique
Mutation
Aberrations des chromosomes
Aberrations des chromosomes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Cannabinoid Receptor Agonists
Diagnostic
5
Caryotype
Analyse cytogénétique
Hybridation in situ
Séquençage génétique
Échographie prénatale
Anomalies congénitales
Conseil génétique
Tests génétiques
Tests sanguins
Anomalies chromosomiques
Symptômes
5
Malformations congénitales
Retard de développement
Troubles mentaux
Développement intellectuel
Anomalies chromosomiques
Symptômes
Types d'aberrations
Gènes
Fertilité
Fausses couches
Prévention
5
Prévention
Conseil génétique
Dépistage prénatal
Anomalies chromosomiques
Traitements
5
Thérapie génique
Recherche
Médicaments
Gestion des symptômes
Suivi médical
Complications
Interventions précoces
Qualité de vie
Complications
5
Complications
Malformations
Problèmes cardiaques
Malformations cardiaques
Troubles du comportement
Anomalies chromosomiques
Qualité de vie
Complications
Facteurs de risque
5
Facteurs de risque
Âge maternel
Substances toxiques
Risque
Antécédents familiaux
Anomalies chromosomiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Aberrations des chromosomes : Questions médicales les plus fréquentes",
"headline": "Aberrations des chromosomes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Aberrations des chromosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Aberrations des chromosomes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mutation",
"url": "https://questionsmedicales.fr/mesh/D009154",
"about": {
"@type": "MedicalCondition",
"name": "Mutation",
"code": {
"@type": "MedicalCode",
"code": "D009154",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Caryotype anormal",
"alternateName": "Abnormal Karyotype",
"url": "https://questionsmedicales.fr/mesh/D059786",
"about": {
"@type": "MedicalCondition",
"name": "Caryotype anormal",
"code": {
"@type": "MedicalCode",
"code": "D059786",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimérisme",
"alternateName": "Chimerism",
"url": "https://questionsmedicales.fr/mesh/D046528",
"about": {
"@type": "MedicalCondition",
"name": "Chimérisme",
"code": {
"@type": "MedicalCode",
"code": "D046528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cassure de chromosome",
"alternateName": "Chromosome Breakage",
"url": "https://questionsmedicales.fr/mesh/D019457",
"about": {
"@type": "MedicalCondition",
"name": "Cassure de chromosome",
"code": {
"@type": "MedicalCode",
"code": "D019457",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.175"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromothripsis",
"alternateName": "Chromothripsis",
"url": "https://questionsmedicales.fr/mesh/D000072837",
"about": {
"@type": "MedicalCondition",
"name": "Chromothripsis",
"code": {
"@type": "MedicalCode",
"code": "D000072837",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.310"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Isochromosomes",
"alternateName": "Isochromosomes",
"url": "https://questionsmedicales.fr/mesh/D018404",
"about": {
"@type": "MedicalCondition",
"name": "Isochromosomes",
"code": {
"@type": "MedicalCode",
"code": "D018404",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.430"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Micronoyaux à chromosomes défectueux",
"alternateName": "Micronuclei, Chromosome-Defective",
"url": "https://questionsmedicales.fr/mesh/D048629",
"about": {
"@type": "MedicalCondition",
"name": "Micronoyaux à chromosomes défectueux",
"code": {
"@type": "MedicalCode",
"code": "D048629",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mosaïcisme",
"alternateName": "Mosaicism",
"url": "https://questionsmedicales.fr/mesh/D009030",
"about": {
"@type": "MedicalCondition",
"name": "Mosaïcisme",
"code": {
"@type": "MedicalCode",
"code": "D009030",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.595"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes en anneau",
"alternateName": "Ring Chromosomes",
"url": "https://questionsmedicales.fr/mesh/D012303",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes en anneau",
"code": {
"@type": "MedicalCode",
"code": "D012303",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aberrations des chromosomes sexuels",
"alternateName": "Sex Chromosome Aberrations",
"url": "https://questionsmedicales.fr/mesh/D012729",
"about": {
"@type": "MedicalCondition",
"name": "Aberrations des chromosomes sexuels",
"code": {
"@type": "MedicalCode",
"code": "D012729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.815"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Caryotype XYY",
"alternateName": "XYY Karyotype",
"url": "https://questionsmedicales.fr/mesh/D014997",
"about": {
"@type": "MedicalCondition",
"name": "Caryotype XYY",
"code": {
"@type": "MedicalCode",
"code": "D014997",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.815.970"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chromosome Philadelphie",
"alternateName": "Philadelphia Chromosome",
"url": "https://questionsmedicales.fr/mesh/D010677",
"about": {
"@type": "MedicalCondition",
"name": "Chromosome Philadelphie",
"code": {
"@type": "MedicalCode",
"code": "D010677",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.870.680"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Disomie uniparentale",
"alternateName": "Uniparental Disomy",
"url": "https://questionsmedicales.fr/mesh/D024182",
"about": {
"@type": "MedicalCondition",
"name": "Disomie uniparentale",
"code": {
"@type": "MedicalCode",
"code": "D024182",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.365.590.175.935"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Aberrations des chromosomes",
"alternateName": "Chromosome Aberrations",
"code": {
"@type": "MedicalCode",
"code": "D002869",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kari Hemminki",
"url": "https://questionsmedicales.fr/author/Kari%20Hemminki",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic."
}
},
{
"@type": "Person",
"name": "Yasmeen Niazi",
"url": "https://questionsmedicales.fr/author/Yasmeen%20Niazi",
"affiliation": {
"@type": "Organization",
"name": "Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany."
}
},
{
"@type": "Person",
"name": "Ludmila Vodickova",
"url": "https://questionsmedicales.fr/author/Ludmila%20Vodickova",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic."
}
},
{
"@type": "Person",
"name": "Pavel Vodicka",
"url": "https://questionsmedicales.fr/author/Pavel%20Vodicka",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic."
}
},
{
"@type": "Person",
"name": "Asta Försti",
"url": "https://questionsmedicales.fr/author/Asta%20F%C3%B6rsti",
"affiliation": {
"@type": "Organization",
"name": "Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism.",
"datePublished": "2023-10-03",
"url": "https://questionsmedicales.fr/article/37834323",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241914874"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36980189",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells12060848"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists.",
"datePublished": "2022-05-22",
"url": "https://questionsmedicales.fr/article/35560866",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/dta.3283"
}
},
{
"@type": "ScholarlyArticle",
"name": "Synthetic cannabinoid receptor agonists are monoamine oxidase-A selective inhibitors.",
"datePublished": "2023-02-21",
"url": "https://questionsmedicales.fr/article/36708234",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/febs.16741"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the Abuse Potential of Lenabasum, a Selective Cannabinoid Receptor 2 Agonist.",
"datePublished": "2024-10-18",
"url": "https://questionsmedicales.fr/article/38936978",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1124/jpet.124.002129"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Variation génétique",
"item": "https://questionsmedicales.fr/mesh/D014644"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mutation",
"item": "https://questionsmedicales.fr/mesh/D009154"
},
{
"@type": "ListItem",
"position": 5,
"name": "Aberrations des chromosomes",
"item": "https://questionsmedicales.fr/mesh/D002869"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Aberrations des chromosomes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Aberrations des chromosomes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Aberrations des chromosomes",
"description": "Comment diagnostique-t-on une aberration chromosomique ?\nQuels tests sont utilisés pour détecter les aberrations chromosomiques ?\nLes échographies peuvent-elles détecter des anomalies chromosomiques ?\nQuel rôle joue le conseil génétique dans le diagnostic ?\nLes tests sanguins peuvent-ils révéler des aberrations chromosomiques ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=Cannabinoid+Receptor+Agonists#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Aberrations des chromosomes",
"description": "Quels sont les symptômes des aberrations chromosomiques ?\nLes aberrations chromosomiques causent-elles des troubles mentaux ?\nPeut-on avoir des symptômes sans aberration chromosomique visible ?\nLes symptômes varient-ils selon le type d'aberration ?\nLes anomalies chromosomiques peuvent-elles affecter la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=Cannabinoid+Receptor+Agonists#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Aberrations des chromosomes",
"description": "Peut-on prévenir les aberrations chromosomiques ?\nLe dépistage prénatal peut-il réduire les risques ?\nLes habitudes de vie influencent-elles les aberrations chromosomiques ?\nLes vaccinations peuvent-elles prévenir des anomalies ?\nLe suivi médical avant la grossesse est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=Cannabinoid+Receptor+Agonists#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Aberrations des chromosomes",
"description": "Quels traitements existent pour les aberrations chromosomiques ?\nLa thérapie génique est-elle une option pour ces anomalies ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nLe suivi médical est-il important pour ces patients ?\nLes interventions précoces sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=Cannabinoid+Receptor+Agonists#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Aberrations des chromosomes",
"description": "Quelles complications peuvent survenir avec des aberrations chromosomiques ?\nLes aberrations chromosomiques augmentent-elles le risque de cancer ?\nLes problèmes cardiaques sont-ils fréquents avec ces anomalies ?\nLes troubles du comportement sont-ils liés aux aberrations chromosomiques ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=Cannabinoid+Receptor+Agonists#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Aberrations des chromosomes",
"description": "Quels sont les facteurs de risque d'aberrations chromosomiques ?\nL'exposition à des substances toxiques augmente-t-elle le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il influencer le risque d'anomalies ?\nLes infections pendant la grossesse sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D002869?mesh_terms=Cannabinoid+Receptor+Agonists#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une aberration chromosomique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par analyse cytogénétique, comme le caryotype."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les aberrations chromosomiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le caryotype, l'hybridation in situ et le séquençage génétique."
}
},
{
"@type": "Question",
"name": "Les échographies peuvent-elles détecter des anomalies chromosomiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent être suspectées par échographie prénatale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le conseil génétique dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le conseil génétique aide à évaluer le risque et à interpréter les résultats des tests."
}
},
{
"@type": "Question",
"name": "Les tests sanguins peuvent-ils révéler des aberrations chromosomiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent détecter des anomalies chromosomiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes des aberrations chromosomiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, incluant des malformations congénitales et des retards de développement."
}
},
{
"@type": "Question",
"name": "Les aberrations chromosomiques causent-elles des troubles mentaux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines aberrations peuvent être associées à des troubles du développement intellectuel."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans aberration chromosomique visible ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent ne pas être visibles mais entraîner des symptômes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'aberration ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type d'aberration et des gènes affectés."
}
},
{
"@type": "Question",
"name": "Les anomalies chromosomiques peuvent-elles affecter la fertilité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines aberrations peuvent entraîner des problèmes de fertilité ou des fausses couches."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les aberrations chromosomiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines aberrations ne peuvent pas être prévenues, mais le conseil génétique aide à évaluer les risques."
}
},
{
"@type": "Question",
"name": "Le dépistage prénatal peut-il réduire les risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage prénatal permet d'identifier les risques d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles les aberrations chromosomiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes, comme l'alcool et le tabac, peuvent augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir des anomalies ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui pourraient causer des anomalies."
}
},
{
"@type": "Question",
"name": "Le suivi médical avant la grossesse est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical peut aider à identifier et gérer les risques avant la grossesse."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les aberrations chromosomiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend des symptômes, incluant thérapies, chirurgie ou soutien éducatif."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces anomalies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces anomalies."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être prescrits pour gérer certains symptômes associés."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important pour ces patients ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est crucial pour surveiller les complications et ajuster les traitements."
}
},
{
"@type": "Question",
"name": "Les interventions précoces sont-elles bénéfiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les interventions précoces peuvent améliorer le développement et la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des aberrations chromosomiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des malformations, des troubles de la croissance et des problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les aberrations chromosomiques augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines aberrations chromosomiques sont associées à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Les problèmes cardiaques sont-ils fréquents avec ces anomalies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines aberrations chromosomiques peuvent entraîner des malformations cardiaques."
}
},
{
"@type": "Question",
"name": "Les troubles du comportement sont-ils liés aux aberrations chromosomiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du comportement peuvent être associés à certaines anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'aberrations chromosomiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge maternel avancé, des antécédents familiaux et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'exposition à des substances toxiques augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des substances toxiques peut augmenter le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'anomalies chromosomiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer le risque d'anomalies ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que le stress peut avoir un impact sur le risque d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les infections pendant la grossesse sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections pendant la grossesse peuvent augmenter le risque d'anomalies chromosomiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 05/05/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany.
Publications dans "Aberrations des chromosomes" :
4 publications dans cette catégorie
Affiliations :
Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Publications dans "Aberrations des chromosomes" :
4 publications dans cette catégorie
Affiliations :
Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
Department of Molecular Biology of Cancer, Institute of Experimental Medicine, of the Czech Academy of Sciences, Videnska 1083, 142 00 Prague, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic.
Publications dans "Aberrations des chromosomes" :
4 publications dans cette catégorie
Affiliations :
Faculty of Medicine and Biomedical Center in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
Department of Molecular Biology of Cancer, Institute of Experimental Medicine, of the Czech Academy of Sciences, Videnska 1083, 142 00 Prague, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00 Prague, Czech Republic.
Publications dans "Aberrations des chromosomes" :
4 publications dans cette catégorie
Affiliations :
Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynaecology, West China Second University Hospital, Sichuan University, No. 20, Section 3, Renminnan Road, Chengdu, 610041, Sichuan, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynaecology, West China Second University Hospital, Sichuan University, No. 20, Section 3, Renminnan Road, Chengdu, 610041, Sichuan, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynaecology, West China Second University Hospital, Sichuan University, No. 20, Section 3, Renminnan Road, Chengdu, 610041, Sichuan, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynaecology, West China Second University Hospital, Sichuan University, No. 20, Section 3, Renminnan Road, Chengdu, 610041, Sichuan, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynaecology, West China Second University Hospital, Sichuan University, No. 20, Section 3, Renminnan Road, Chengdu, 610041, Sichuan, China. huting4123@163.com.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China. huting4123@163.com.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
KBR, Houston, TX 77058, USA.
NASA Johnson Space Center, Houston, TX 77058, USA.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
GeneWerk GmbH, Heidelberg, Germany.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia.
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia.
First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University, Prague, Czechia.
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.
Publications dans "Aberrations des chromosomes" :
3 publications dans cette catégorie
Affiliations :
Institute of Human Genetics, School of Medicine and University Hospital Bonn, University of Bonn, Bonn, Germany.
Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
Publications dans "Aberrations des chromosomes" :
Synthetic cannabinoid receptor agonists (SCRAs) have become a wide group of new psychoactive substances since the 2010s. For the last few years, the X-ray structures of the complexes of cannabinoid re...
Cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) are components in the endocannabinoid system that play significant roles in regulating immune responses. There are many agonists for the c...
In recent years, several nations have implemented various measures to control the surge of new synthetic cannabinoid receptor agonists (SCRAs) entering the recreational drug market. In July 2021, Chin...
Synthetic cannabinoid receptor agonists (SCRAs) are one of the fastest growing classes of recreational drugs. Despite their growth in use, their vast chemical diversity and rapidly changing landscape ...
Endocannabinoids, which are present throughout the central nervous system (CNS), can activate cannabinoid receptors 1 and 2 (CB1 and CB2). CB1 and CB2 agonists exhibit broad anti-inflammatory properti...
Since late 2019, fortification of 'regular' cannabis plant material with synthetic cannabinoid receptor agonists (SCRAs) has become a notable phenomenon on the drug market. As many SCRAs pose a higher...
The assay principle relies on the functional complementation of a split-nanoluciferase following recruitment of β-arrestin 2 to activated CB...
The bioassay successfully detected all samples of a set (n = 24) of analytically confirmed authentic Spice products, additionally providing relevant information on the 'strength' of a preparation and ...
In summary, we established SCRA screening of herbal materials as a new application for the activity-based CB...
Partial agonists of peripheral cannabinoid receptors (CBRs) have potential therapeutic applications in several medical conditions. However, (-)-trans-Δ...
Cannabinoid receptor ligands are renowned as being therapeutically crucial for treating diverse health disorders. Phenylspirodrimanes are meroterpenoids with unique and varied structural scaffolds, wh...
The emergence of synthetic cannabinoid receptor agonists (SCRAs) as illicit psychoactive substances has posed considerable public health risks, including fatalities. Many SCRAs exhibit much higher eff...
Following the class-wide ban of synthetic cannabinoid receptor agonists (SCRAs) in China, SCRAs carrying new core and linker structures, aimed at circumventing the recent Chinese generic legislation, ...